Ranitidine for Molluscum Contagiosum in Children

Evidence Against Ranitidine for Molluscum Contagiosum

The British Association of Dermatologists guidelines mention ranitidine only in the context of wart treatment, not molluscum contagiosum, with limited evidence even for warts 1
Current guidelines from the American Academy of Pediatrics and American Academy of Dermatology do not include ranitidine among recommended treatments for molluscum contagiosum 2, 3

10% potassium hydroxide solution has similar efficacy to cryotherapy in children and is recommended by the American Academy of Pediatrics 2
Cantharidin has shown effectiveness in observational studies, though randomized controlled trial evidence is limited 2

For children under 2 years, salicylic acid is contraindicated due to risk of systemic toxicity 3
Watchful waiting is a reasonable approach as molluscum contagiosum typically resolves spontaneously within 6-12 months 3

Confirm diagnosis by identifying characteristic skin-colored, whitish, or pink papules with central umbilication, typically on the trunk, face, and extremities 4
Assess extent of disease and presence of complications such as associated conjunctivitis if lesions are near the eyes 2
Consider patient's age, location of lesions, number of lesions, and presence of symptoms when selecting treatment 2, 3
For extensive or recalcitrant disease, consider screening for immunocompromised state 2

Avoid using ranitidine or other H2 blockers for molluscum contagiosum as there is no evidence supporting their efficacy for this condition 1, 2
Be aware that ranitidine's primary indication is for gastroesophageal reflux and reducing gastric hypersecretion, not for dermatological conditions 5
Do not use salicylic acid in children under 2 years due to risk of systemic toxicity 3